Extended follow-up studies are needed to assess the durability of weight loss, improvements in OSA severity, and cardiovascular benefits
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
Net cost differences were AU$4.2 billion for SGLT2is and AU$20.2 billion for GLP-1 RAs, and the ICERs were AU$23,717 and AU$100,705 per QALY gained, respectively
Costco Prescription Program : Free prescription discount program available to everyone that offers savings up to 80% on select drugs at over 64,000 pharmacies in the US
Multicenter ophthalmic and nutritional age-related macular degeneration study part 2: antioxidant intervention & conclusions
Consider these risks when prescribing or dispensing Benzhydrocodone and Acetaminophen tablets